Wave Life Sciences Ltd. Ordinary Shares (WVE)

About WVE

Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 anti…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

317

Website

wavelifesciences.com

Fundamentals

1-day range

$5.14$5.42

Market cap

$1.13B

P/E (trailing)

—

P/E (forward)

-4.54

EPS (trailing)

$-1.08

Dividend yield

—

Beta

-1.29

Avg. volume

3.25M

Forecasts

16 analyst ratings

Wave Life Sciences Ltd. Ordinary Shares Competitors

Chosen by industry and closest market cap.

• WVE

  Wave Life Sciences Ltd. Ordinary Shares

  $5.04

  ▼ 2.33%
  Market cap $1.13BP/E —
  $5.01$21.73
• CRVS

  Corvus Pharmaceuticals Inc. Common Stock

  $14.15

  ▼ 3.87%
  Market cap $1.12BP/E —
  $5.28$26.95
• SDGR

  Schrodinger Inc. Common Stock

  $19.7

  ▼ 3.48%
  Market cap $1.14BP/E —
  $10.95$23.02
• SVRA

  Savara Inc. Common Stock

  $5.27

  ▼ 4.10%
  Market cap $1.09BP/E —
  $3.19$7.01
• MNKD

  MannKind Corporation Common Stock

  $3.96

  ▼ 2.59%
  Market cap $1.21BP/E —
  $2.23$6.51
• LXRX

  Lexicon Pharmaceuticals Inc. Common Stock

  $2.29

  ▼ 1.29%
  Market cap $1.03BP/E —
  $1.03$2.68
• LBRX

  LB Pharmaceuticals Inc Common Stock

  $47.8

  ▼ 0.20%
  Market cap $1.23BP/E —
  $13.36$50.16

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Wave Life Sciences: An Fairly Valued RNA Opportunity
  SeekingAlpha · 8/12/2026
• Prime Medicine: An Initial Prognosis
  SeekingAlpha · 8/11/2026
• Wave Life Sciences Ltd. (WVE) Presents at Bank of America SMID Cap Virtual Conference Transcript
  SeekingAlpha · 8/11/2026
• Did U.S. Redomiciliation and Mixed 1H 2026 Results Just Shift Wave Life Sciences' (WVE) Investment Narrative?
  Yahoo · 8/7/2026
• Wave Life Sciences Announces Expected Completion Date for Redomiciliation to Delaware
  Yahoo · 8/5/2026
• Mizuho Maintains Outperform on WAVE Life Sciences, Lowers Price Target to $23
  Benzinga · 8/4/2026
• Wave Life Sciences to Present at Upcoming Investor Conferences
  Yahoo · 8/4/2026
• Wave Life Sciences (WVE) Q2 2026 Earnings Call Transcript
  Yahoo · 8/4/2026

• Adrian Rawcliffe · August 12, 2026 · Sale

  12.7K @ $5.29
• Heidi L. Wagner · August 11, 2026 · Option Exercise

  7.0K @ $5.97
• Heidi L. Wagner · August 11, 2026 · Sale

  7.0K @ $6.01
• Ken Takanashi · August 11, 2026 · Sale

  3.9K @ $6.01
• Aik Na Tan · August 11, 2026 · Sale

  432 @ $6.01
• RA Capital Healthcare Fund LP · March 30, 2026 · Buy

  971.1K @ $6.5
• RA Capital Healthcare Fund LP · March 27, 2026 · Buy

  2.50M @ $6.43
• RA Capital Healthcare Fund LP · March 26, 2026 · Buy

  351.2K @ $6.38
• RA Capital Healthcare Fund LP · March 26, 2026 · Buy

  4.95M @ $6.06
• Ken Takanashi · March 23, 2026 · Conversion

  3.90M